Trial intelligence / Profile preview

Nebulised Inhalational Steroids in Meconium Aspiration Syndrome

NCT07763119Phase 3Completed

Sponsor
Khyber Teaching Hospital
Start
Nov 2025
Primary completion
Apr 2026
Countries
1
01

Overview

A Phase 3 trial of budesonide in Meconium aspiration syndrome (MAS), sponsored by Khyber Teaching Hospital. Started Nov 2025; status: completed.

02

Drugs

budesonide
03

Conditions

Meconium aspiration syndrome (MAS)

Beyond the preview

Go deeper on NCT07763119.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07763119.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call